eScholarship
metadata only
CC BY
Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential
Decreased dendritic spine density in the cortex is a key pathological feature of neuropsychiatric diseases including depression, addiction, and schizophrenia (SCZ). Psychedelics possess a remarkable ability to promote cortical neuron growth and increase spine density; however, these compounds are co
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effects of LSD, DMT and psilocybin on cognitive and psychological functions: A systematic review of the literature.#415618
- Psychedelics: Recent Philosophical Discussions#111096
- Psychedelics and Autism Therapy: A Review of Current Research and Future Directions.#140538
- The role of modern neuroscience in the renaissance of psychedelic research.#1167187
- Controlled Substances in the New Administration: Cannabis, Psychedelics, and Opioids#168661
Record · ID 1283493
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive